Alkem Laboratories Limited (ALKEM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.061x

Based on the latest financial reports, Alkem Laboratories Limited (ALKEM) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs8.37 Billion ≈ $90.47 Million USD) by net assets (Rs138.11 Billion ≈ $1.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Alkem Laboratories Limited defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Alkem Laboratories Limited - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Alkem Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Alkem Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alkem Laboratories Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
JSW Infrastructure Limited NSE:JSWINFRA	0.112x
SODEXO S.A. ADR/ 1/5 EO 4 F:SJ70	N/A
SIGMASTAR TECH LTD SHE:301536	0.035x
Nedbank Group Ltd JSE:NED	0.100x
Shanghai Electric Power Co Ltd SHG:600021	0.127x
Synovus Financial Corp NYSE:SNV	0.035x
Technology One Ltd AU:TNE	0.496x
Dpm Metals Inc. AU:DPM	0.056x

Annual Cash Flow Conversion Efficiency for Alkem Laboratories Limited (2010–2025)

The table below shows the annual cash flow conversion efficiency of Alkem Laboratories Limited from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Alkem Laboratories Limited.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs124.34 Billion ≈ $1.34 Billion	Rs19.13 Billion ≈ $206.87 Million	0.154x	-15.39%
2024-03-31	Rs107.14 Billion ≈ $1.16 Billion	Rs19.48 Billion ≈ $210.68 Million	0.182x	+1.96%
2023-03-31	Rs94.35 Billion ≈ $1.02 Billion	Rs16.82 Billion ≈ $181.96 Million	0.178x	+42.00%
2022-03-31	Rs88.47 Billion ≈ $956.81 Million	Rs11.11 Billion ≈ $120.15 Million	0.126x	-24.97%
2021-03-31	Rs75.58 Billion ≈ $817.37 Million	Rs12.65 Billion ≈ $136.79 Million	0.167x	+80.46%
2020-03-31	Rs63.09 Billion ≈ $682.29 Million	Rs5.85 Billion ≈ $63.27 Million	0.093x	-33.53%
2019-03-31	Rs55.72 Billion ≈ $602.59 Million	Rs7.77 Billion ≈ $84.07 Million	0.140x	+151.85%
2018-03-31	Rs49.85 Billion ≈ $539.14 Million	Rs2.76 Billion ≈ $29.87 Million	0.055x	-46.11%
2017-03-31	Rs45.83 Billion ≈ $495.62 Million	Rs4.71 Billion ≈ $50.95 Million	0.103x	-46.36%
2016-03-31	Rs37.87 Billion ≈ $409.55 Million	Rs7.26 Billion ≈ $78.50 Million	0.192x	+81.66%
2015-03-31	Rs30.85 Billion ≈ $333.60 Million	Rs3.25 Billion ≈ $35.20 Million	0.106x	-3.41%
2014-03-31	Rs26.55 Billion ≈ $287.14 Million	Rs2.90 Billion ≈ $31.37 Million	0.109x	+65.86%
2013-03-31	Rs23.74 Billion ≈ $256.72 Million	Rs1.56 Billion ≈ $16.91 Million	0.066x	+5.93%
2012-03-31	Rs19.06 Billion ≈ $206.08 Million	Rs1.18 Billion ≈ $12.81 Million	0.062x	-91.34%
2011-03-31	Rs11.67 Billion ≈ $126.25 Million	Rs8.38 Billion ≈ $90.62 Million	0.718x	+1128.81%
2010-03-31	Rs12.05 Billion ≈ $130.35 Million	Rs-840.93 Million ≈ $-9.09 Million	-0.070x	--

About Alkem Laboratories Limited

NSE:ALKEM India Drug Manufacturers - Specialty & Generic

Market Cap

$6.95 Billion

Rs642.48 Billion INR

Market Cap Rank

#2929 Global

#131 in India

Share Price

Rs5373.50

Change (1 day)

+0.03%

52-Week Range

Rs4732.80 - Rs5890.00

All Time High

Rs6366.25